Vesparum Capital

Vesparum Capital is a leading independent capital markets advisory firm headquartered in Melbourne, Australia, with a primary focus on the life sciences and healthcare sectors. The firm provides strategic financial advice to boards and management teams, specializing in initial public offerings (IPOs), secondary capital raisings, and mergers and acquisitions. Vesparum distinguishes itself through a data-centric approach to investor relations and capital structure optimization, particularly within the Australian Securities Exchange (ASX) environment. By leveraging deep industry expertise, the firm assists biotech and medtech companies in navigating complex regulatory and financial landscapes to achieve long-term growth.